{"slug":"roche-launches-nvidia-ai-factory-to-accelerate-the-development-of-new-therapeutics-and-diagnostics-solutions","url":"https://findausecase.com/use-cases/roche-launches-nvidia-ai-factory-to-accelerate-the-development-of-new-therapeutics-and-diagnostics-solutions","title":"Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions","description":"Roche deployed 2,176 NVIDIA Blackwell GPUs on premises across the United States and Europe, bringing its combined on-premise and cloud GPU infrastructure to more than 3,500 Blackwell GPUs. The AI factory is embedded across the value chain: NVIDIA BioNeMo powers Roche's Lab-in-the-Loop strategy connecting biological and chemistry experiments with AI models in R&D; NVIDIA Omniverse-powered digital twins optimize manufacturing production lines and factory designs; accelerated computing and NVIDIA Parabricks analyze diagnostics datasets and digital pathology images; and NVIDIA NeMo Guardrails support healthcare-grade conversational AI in digital health. The expansion builds on a NVIDIA collaboration that started in 2023, and Roche's U.S. subsidiary Genentech also leverages the infrastructure for drug discovery.","company":"Roche","industry":"Pharmaceuticals","country":"Switzerland","aiCapabilities":["Generative AI","Predictive Analytics","Conversational AI","Computer Vision"],"technology":["NVIDIA Blackwell","NVIDIA BioNeMo","NVIDIA Omniverse","NVIDIA Parabricks","NVIDIA NeMo Guardrails"],"deployment":"Hybrid","problemStatement":"Roche needed significantly greater computational infrastructure to accelerate drug and diagnostics development across its value chain -- from discovery and development to manufacturing, diagnostics and commercialization -- as part of its vision to build an AI-accelerated healthcare organization.","solutionApproach":"Roche deployed 2,176 additional NVIDIA Blackwell GPUs on premises across the United States and Europe, expanding its combined on-premise and cloud GPU infrastructure to more than 3,500 Blackwell GPUs, as the next phase of a strategic NVIDIA collaboration that started in 2023. The AI factory is embedded across the value chain: NVIDIA BioNeMo powers Roche's Lab-in-the-Loop strategy connecting biological and chemistry experiments with Roche's AI models in R&D; NVIDIA Omniverse-powered digital twins let engineers optimize production lines and factory designs in manufacturing; accelerated computing and NVIDIA Parabricks software enable insights across vast diagnostics datasets and scan large numbers of digital pathology images to detect subtle disease patterns; and Roche uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade conversational AI in digital health.","businessValue":"Roche now operates the pharmaceutical industry's largest announced hybrid-cloud AI factory, with more than 3,500 Blackwell GPUs -- the greatest announced GPU footprint available to a pharmaceutical company. Roche's Lab-in-the-Loop approach helps scientists test hypotheses at scale, accelerate progress, and make discoveries that were not possible otherwise; Genentech's Aviv Regev said the added computational power lets scientists build more sophisticated predictive frontier models and further shorten the path from biological insight to life-saving medicine.","evidence":{"band":"high"},"sourceUrl":"https://www.roche.com/media/releases/med-cor-2026-03-16","dates":{"publishedAt":"2026-08-22T09:03:57.016Z","publishedAtSource":"pipeline","updatedAt":"2026-08-22T09:03:57.016Z"},"license":"Open for reading and citing with a link to https://findausecase.com/use-cases/roche-launches-nvidia-ai-factory-to-accelerate-the-development-of-new-therapeutics-and-diagnostics-solutions. Bulk republication requires permission."}